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Abstract 
Purpose 
To determine the surgical outcome after initial surgery in children with primary 
developmental glaucoma (PDG). 
Methods 
Six hundred and twenty-four eyes of 360 consecutive patients who underwent primary 
combined trabeculotomy–trabeculectomy (CTT) for PDG from January 1990 to June 2004 
were studied. The main outcome measures were pre- and postoperative intraocular pressures 
(IOPs), corneal clarity, visual acuities, refractive errors, success rate, time of surgical failure, 
complications, and factors associated with poor outcome. 
Results 
IOP reduced from 28.1 7.5 to 14.9 5.9 mmHg (P<0.0001). Probability of success 
(IOP<21 mmHg) was 85.2, 80.4, 77.2, 72.6, 66.2, and 57.5% at first, second, third, fourth, 
fifth, and sixth years, respectively (Kaplan–Meier analysis). The mean follow-up period was 
20.3 25.6 months (median, 6 months). Preoperatively, 243 eyes (67.5%) had significant 
corneal oedema. Postoperatively, normal corneal transparency was achieved in 162 eyes 
(46.0%). Data on Snellen visual acuity were available in 100 patients (27.8%). At the final 
follow-up visit, 42 patients (42.0%) had normal visual acuity ( 20/60). Myopia (mean 
spherical equivalent, 6.1 D) was the most common (75.0%) refractive error. In multivariate 
analyses, failure increased by three-fold in the presence of preoperative IOP>35 mmHg 
(hazards ratio (HR)=3.12; 95% confidence interval (CI), 1.4–6.7) and two-fold in cases with 
a history of prior glaucoma surgery (HR=2.57; 95% CI, 1.1–6.0). There were no major 
intraoperative complications, bleb-related infection, or endophthalmitis. 
Conclusions 
This series shows that prolonged IOP control can be achieved in patients with PDG and 42% 
of the patients gained normal visual acuity. 
Keywords 
developmental glaucoma; surgical outcome, trabeculotomy, trabeculectomy, combined 
trabeculotomy and trabeculectomy, megalocornea 
Primary developmental glaucoma (PDG) is a potentially blinding disease, which is refractive 
to medical treatment.1 Early diagnosis and prompt microsurgical intervention has been 
advocated by several investigators.1, 2, 3, 4, 5 Goniotomy has traditionally been regarded as the 
procedure of choice.2, 4, 6, 7, 8 However, the best approach to the surgical treatment of PCG is a 
subject of considerable debate.9, 10, 11, 12, 13 The developmental glaucoma, which occurs in 
India,14, 15 Middle East,16 and in several other parts of the world, is more often familial than it 
is in the West17 and responds less favourably to goniotomy. In such cases, trabeculotomy ab 
externo is advocated as the initial surgical procedure of choice by several authors.10, 12, 13, 18, 19, 
20, 21, 22, 23 Management of PDG is further complicated, as multiple surgical interventions are 
often required for the control of intraocular pressure (IOP).2, 4, 8, 24, 25, 26 In the search for the 
best surgical treatment of developmental glaucoma, combined trabeculotomy–trabeculectomy 
(CTT) owing to its obvious advantages over conventional procedures has emerged as the new 
treatment modality.27, 28, 29 Over the last decade, the good success rate of CTT reported by 
Elder28 has been substantiated by other institutions and paediatric ophthalmologists.30, 31, 32, 33, 
34, 35, 36 
The functional outcome of patients with PDG is poor; no more than 40–50% of these children 
achieve a vision of 20/50 or better.24, 25 However, only a few reports exist on the long-term 
surgical outcome in developmental glaucoma.2, 4, 23, 24, 25, 32, 34, 35, 36 The primary objective of 
the present study was to evaluate the surgical outcome after CTT for PDG in 360 consecutive 
children (624 eyes) who were operated upon by a single surgeon over a 14.5-year period in a 
tertiary eye care centre in India. The secondary objective was to identify clinically relevant 
factors that were associated with a poor outcome. 
Methods 
Study design 
We conducted a retrospective chart review of all records of children who underwent CTT for 
PDG at the LV Prasad Eye Institute (LVPEI), Hyderabad, India from 1 January 1990 to 30 
June 2004. In case of bilateral affliction, the choice of simultaneous bilateral surgery was 
offered to all patients after thoroughly discussing the risks and benefits with the parents. All 
surgeries were performed by a single surgeon (AKM) who was also present at almost all 
follow-up examinations. Before surgery, an informed consent was obtained from the parents 
of all patients. We excluded patients with a follow-up of less than 3 months from the present 
study. The use of primary CTT as the main therapeutic modality was approved by the Ethics 
Committee for Human Research at LVPEI. 
Examination procedures 
All patients underwent ophthalmological examinations, including applanation tonometry 
using Perkin's hand-held applanation tonometer in children who were examined under 
anaesthesia and using Goldmann applanation tonometer in children old enough for slit-lamp 
examination. Various suitable age-appropriate procedures were used to assess visual acuity. 
These included grating acuity assessment using Teller Acuity Cards37 (TAC) (Vistech 
Consultants Inc., Dayton, OH, USA) for infants and toddlers, using a method similar to that 
described by Trueb et al38 The grating acuity was, however, converted to Snellen equivalent 
for purposes of analysis and comparison, and acuities within the 99% prediction limits for the 
child's age were recorded as normal, based on the norms provided by Mayer et al39 Other 
assessment procedures included a 3-m folding chart containing Lea symbols40 for 
preschoolers and the logMAR chart for school-aged children and adolescents.41 For children 
to whom these procedures could not be applied, the ability to fix and follow light using a pen 
torch was recorded. Although the ability to fix and follow a light does not provide a measure 
of visual acuity, it can help identify children who are totally blind.42 Retinoscopy was 
performed manually using a streak retinoscope (Heine, Beta 2000) under cycloplegia (1% 
cyclopentolate hydrochloride eye drops) in the postoperative period after 6 weeks in eyes 
with clear corneas. It was performed in the office on cooperative children and during 
examination under anaesthesia (EUA) for uncooperative children. In such children, the 
refractive correction was prescribed based on the objective value after appropriate 
adjustments for cycloplegia. In cooperative children in whom the retinoscopic reflex was 
irregular and dull owing to the presence of a corneal scar, subjective procedures such as axial 
length measurements and keratometry were used to obtain a rough estimate, which was then 
used as a baseline value for further refinements in the subjective refraction.43, 44 Any child 
whose best-corrected spectacle acuity was below 20/60 was referred to the vision 
rehabilitation centres for further management. These results are not reported as they are 
outside the scope of the present study. 
Visual acuity was reported according to the World Health Organization classification of 
visual impairment.45 These categories have been defined based on the best-corrected visual 
acuity in the better eye and consist of (a) low vision (<20/60–20/400) and (b) blindness 
(<20/400). 
Data analysis and recording 
All preoperative, surgical, and postoperative parameters were entered into a Microsoft excel 
database. Any intra- and perioperative surgical complications and re-treatments were also 
recorded. 
Outcome measures 
The outcome measures included preoperative and postoperative IOPs, corneal clarity and 
diameter, visual acuity, success rate, bleb characteristics, time of surgical failure, and 
complications. The incidence of endophthalmitis (if any) and anaesthetic morbidity and 
mortality were analysed. 
Surgical procedure 
The surgical technique employed in all cases was primary CTT. This technique has 
previously been described by us.32, 46, 47 In brief, the Schlemm's canal was dissected under a 
partial thickness limbal-based triangular scleral flap, and trabeculotomy ab externo was 
performed on both sides of the radial incision. Trabeculectomy was then performed in the 
usual manner. In cases of bilateral affliction, after completion of surgery on the first eye, the 
second eye was operated using a similar technique but with a new set of instruments, drapes, 
drops, gown, gloves, etc, simulating a surgical procedure on a different patient. 
Postoperative regimen 
A standard postoperative care regimen was followed for all patients. In the immediate 
postoperative period, all the patients received topical 1% cyclopentolate hydrochloride 
combined with a corticosteroid-antibiotic preparation that was tapered gradually over a 6-
week period. All patients were examined 1, 2, and 3 days after surgery, followed by 
examination in the office at the end of 1, 3, and 6 weeks and in the office every 3 months 
thereafter. At each visit, patients were examined fully with a slit-lamp biomicroscope, and the 
anterior chamber depth, corneal appearance, IOP, bleb appearance, and fundus picture were 
documented. Patients who could not be examined in the office were scheduled for EUA at the 
end of 1, 3, and 6 weeks and every 3 months thereafter. 
Success criteria 
Surgical success and failure were defined before data analysis. The surgery was considered a 
complete success when the IOP was less than 16 mmHg in patients examined under general 
anaesthesia or less than 21 mmHg in patients who were old enough to be examined with the 
slit lamp and when there was no progression of disc cupping or corneal diameter. Success 
was deemed qualified success if ocular antihypertensive agents were required to maintain 
these criteria. Failure was defined as uncontrolled IOP despite additional medical therapy, 
developing hypotony-related maculopathy or sight-threatening complications, or requiring 
additional surgery. 
Statistical analysis 
To avoid bias, we evaluated the results in terms of patients rather than eyes.48 For the purpose 
of statistical analysis, only one randomly chosen eye was included for patients with a bilateral 
affliction. In cases of unilateral affliction, the affected eye was included. Descriptive statistics 
are given as mean and standard deviation (SD). Cumulative success probability was 
determined using Kaplan–Meier survival analysis. Spherical equivalent (SE) was used to 
analyse the refractive errors. SE was calculated by adding half the cylindrical value to the 
spherical value of the refractive error. Subjects with SE higher than +0.50 D were considered 
as having hyperopia and SE -0.50 D was considered for analysis of myopia. 
The effect of individual clinical and demographic variables on the outcome of treatment was 
analysed by a series of univariate Cox proportional hazards models.49 Any factor with P<0.15 
from the univariate analysis was subjected to a multivariate analysis using the forward 
stepwise method. The effect of each category of a two-category variable was assessed by 
keeping either of the two categories as the reference. Results are expressed as hazards ratio 
(HR) with 95% confidence intervals. P<0.05 was considered as statistically significant. 
Using the SPSS (SPSS for Windows, version 10.0, SPSS, Chicago, IL, USA) statistical 
package, analyses of continuous data were made using the paired 't' test. Ordinal data were 
analysed by the Wilcoxon signed rank test. 
Results 
Demographic data 
The study group included 360 consecutive patients (624 eyes) who underwent CTT. Three 
hundred and thirty patients (91.7%) underwent CTT as an initial glaucoma surgery, whereas 
30 patients (8.3%) underwent CTT as the second surgical intervention, in whom the primary 
glaucoma surgery was performed elsewhere. Table 1 summarizes the demographics of our 
study population. The mean age at surgery was 31.9 54.6 months (range, 0–353.13 months; 
median, 6.5 months). The study population primarily had PDG (360, 100%). Two hundred 
and sixty-four (73.3%) patients were affected in both eyes. Follow-up averaged 20.3 25.6 
months (range, 3–120 months; median, 6 months). 
Table 1 - Patient demographics (360 patients (624 eyes) with developmental glaucoma). 
Demographics  No. (%)  
Age at surgery (months)  
 Mean 31.9 54.6 
 Range 0–353.1 
 Median 6.5 
Race  
 White 0 
 Black 0 
 Asian 360 (100) 
Gender  
 Male 204 (56.7) 
 Female 156 (43.3) 
Corneal diameter at presentation (mm)  
 Mean 13.0 1.4 
 Range 6.5–18.0 
Corneal clarity at presentation  
 Clear 81 (22.6) 
 Oedema 243 (67.9) 
 Scarring 34 (9.5) 
Corneal clarity at last visit a  
 Clear 162 (46.0) 
Preoperative IOP (mmHg) (mean SD) 28.1 7.5 
Postoperative IOP (mmHg) (mean SD) 14.9 5.9 
Preoperative medications (mean) 0.6 0.7 
Postoperative medications (mean) 0.2 0.4 
Reduction of IOP (%) 42.6 29.9 
Follow-ups (months)  
 Mean SD 20.3 25.6 
 Median 6 
 IOP, intraocular pressure; SD, standard deviation. 
a Data regarding corneal clarity were not available for one eye. 
  
Intraocular pressure 
Preoperatively, the mean IOP was 28.1 7.5 mmHg (range, 10–56 mmHg) with patients using 
an average of 0.6 0.7 medications. On the last follow-up visit, the IOP averaged 14.9
5.9 mmHg (range, 1–42 mmHg) (P<0.0001, paired t-test) with a mean of 0.2 0.4 
medications (P<0.0001, Wilcoxon signed rank test). Preoperatively, 170 of 360 eyes (47.2%) 
were on antiglaucoma medication, whereas at the last follow-up, 63 of 360 eyes (17.5%) 
required antiglaucoma medication. Although some of the patients had normal IOP 
preoperatively, they were operated upon because they were on antiglaucoma medication and 
the diagnosis of glaucoma was confirmed based on a comprehensive ocular examination that 
included corneal diameters. 
Corneal diameter and clarity 
At presentation, mean ( SD) horizontal corneal diameters were 13.0 1.4 mm (range, 6.5–
18.0 mm). Preoperatively, approximately one-fifth of the eyes (75, 22.3%) had normal 
corneal transparency and the decision for surgery in these eyes was based on high IOP, 
megalocornea, and gonioanamoly suggestive of developmental glaucoma. Two hundred and 
forty-three eyes (67.9%) had varying degrees of corneal oedema. Thirty-four eyes (9.5%) had 
corneal scarring. At the final follow-up visit, corneal clarity data were not available for 7 
eyes. One hundred and sixty two (46.0 %) had normal corneal transparency, 118 eyes (33.5 
%) corneal oedema, and 72 eyes (20.5%) corneal scarring. The improvement in corneal 
transparency was statistically significant (P<0.0001). The preoperative and postoperative 
clinical photographs of congenital, infantile, and juvenile-onset developmental glaucomas are 
depicted in Figures 1a–f. 
Figure 1 
(a) Clinical appearance of a 1-week-old child 
showing bilateral corneal oedema resulting from 
congenital glaucoma.  
(b) Six-month postoperative photograph of the 
child seen in (a).  
(c) Clinical appearance of a 6-month-old child 
showing megalocornea and corneal oedema of 
the left eye resulting from infantile glaucoma.  
(d) Five-year postoperative photograph of the 
child seen in (c).  
(e) Clinical appearance of a 3-year-old child 
showing bilateral buphthalmos resulting from 
juvenile-onset developmental glaucoma.  
(f) Ten-year postoperative photograph of the child 





Visual acuity data were available for approximately two-third of the patients (229, 63.6%). 
Of these, best-corrected Snellen visual acuity could be recorded for 100 patients (27.8%). In 
the remaining patients, grating acuity using TAC was recorded. However, for the purpose of 
reporting, we analysed Snellen acuity data only. At the final postoperative visit, 42 patients 
(42.0%) achieved normal visual acuity ( 20/60). Thirty-one (31.0%) patients had low vision 
and 27 (27.0%) were blind as defined by WHO criteria of vision loss. 
Refractive errors 
Data regarding refractive status were available for 202 (56.1%) patients. Approximately 
three-quarter of the eyes (149, 73.8%) were myopic with mean SE of 6.0 4.9 D (range, 0.75–
32.0 D). Twenty-seven eyes (13.4%) were emmetropic and the remaining 26 eyes (12.9%) 
were hypermetropic with mean SE of 3.9 4.7 D (range, 0.75–21.0 D). 
Success rate 
Figure 2 demonstrates Kaplan–Meier survival curve of the entire group. Complete success as 
defined in the present study was obtained in 279 eyes (77.5%). Kaplan–Meier survival 
analysis revealed 12-, 24- 36-, 48-, 60-, 72-, and 84-month success rates of 85.2 2.3, 80.4
2.9, 77.2 3.3, 72.6 4.1, 66.2 5.2, and 57.5 6.6%, respectively, that was maintained for 8 
years of follow-up. Qualified success was obtained in 19 eyes (5.3%), whereas 62 eyes 
(17.2%) were considered to be failures. 




Factors associated with poor functional outcome 
Table 2 presents univariate and multivariate comparisons of final surgical outcome according 
to several patient characteristics. In univariate analysis, the failure rate was higher in patients 
who were older than 6 months at the time of surgery than in those who were younger than 6 
months of age (Figure 3) at the time of surgery (21.4 vs 12.8%; HR=1.98). Patients who 
presented with IOP>35 mmHg performed significantly worse (Figure 4) than those with IOP
35 mmHg (31.9 vs 15.1%; HR=2.43). Patients who underwent prior glaucoma surgery had 
greater chances of failure with CTT as the second procedure (43.3 vs 14.8%; HR=3.17). No 
significant associations (P<0.05) were found with the other factors evaluated. In multivariate 
analyses, the significant factors were the preoperative IOP>35 mmHg and a history of prior 
glaucoma surgery (Table 2). Patients who presented with IOP>35 mmHg had twice the risk 
of failure (HR=3.12) as compared with those who presented with IOP 35 mmHg. Patients 
who underwent prior glaucoma surgery had thrice the risk of failure (HR=2.57) as compared 
with those who underwent CTT as an initial surgical procedure. There were five patients who 
presented with a history of prior glaucoma surgery and uncontrolled glaucoma with 
IOP>35 mmHg; four (80%) of these patients failed and the risk of failure doubled (HR=6.42) 
when the two factors (IOP>35 mmHg and prior surgery) co-existed as opposed to when they 
contributed individually. 
Figure 3. Kaplan–Meier success probability of CTT for patients with developmental glaucoma. 
Success probability of patients who underwent surgery within 6 months of age is significantly 
(P=0.005) better than those who were older than 6 months at the time of surgery. 
 
Figure 4. Kaplan–Meier success probability of CTT for patients with developmental glaucoma. 
Success probability of patients who had preoperative IOP 35 mmHg is significantly (P=0.005) 
better than those with preoperative IOP >35 mmHg. 
 
Table 2 - Effect of age at surgery, gender, preoperative IOP, corneal diameter, and history of 
previous glaucoma surgery on outcome. 
  Total N=360 Failure no. (%)  HR 
a (95% CI)  P-value HR b (95% CI)  
Age at surgery c  
 6 months 187 24 (12.8) 1.00 0.010 1.00 
 >6 months 168 36 (21.4) 1.98 (1.2–3.3)  1.20 (0.6–2.4) 
Gender  
 Female 149 25 (16.0) 1.00 0.791 — 
 Male 204 37 (18.1) 1.07 (0.6–1.8)    
Preop. IOP (mmHg)  
 35 312 47 (15.1) 1.00 0.003 1.00 
 >35 47 15 (31.9) 2.43 (1.4–4.4)  3.12 (1.4–6.7) 
Hor. corneal dia. d (mm)  
 14 201 30 (14.9) 1.00 0.150 1.00 
 >14 89 19 (21.3) 1.53 (0.9–2.7)  1.04 (0.5–2.1) 
Previous glau. surg.  
 No 330 49 (14.8) 1.00 <0.0001 1.00 
 Yes 30 13 (43.3) 3.17 (1.7–5.7)  2.57 (1.1–6.0) 
CI, confidence interval; Hor. corneal dia., horizontal corneal diameter; IOP, intraocular pressure; 
Preop., preoperative; Previous glau. surg., previous glaucoma surgery. 
a Univariate analysis 
b Multivariate analysis 
c The data on age at the time of surgery were not available for five patients. 
d The data on horizontal corneal diameter were not available for 70 patients. 
Complications 
Operative complications 
Operative complications were encountered in 64 of 360 eyes (17.8%) and are listed in Table 
3. There was no sight-threatening intraoperative complication. Of the minor postoperative 
complications, the most common one was shallow anterior chamber, which occurred in 51 
(14.2%) eyes in the first postoperative week; however surgical reformation was required in 
only eight (15.7%) of these eyes and in the remainder (43 eyes, 84.3%) the anterior chamber 
deepened spontaneously. One eye (0.3%) developed choroidal detachment that was 
successfully managed conservatively. Four eyes (1.1%) required enucleation because of 
painful blind eye secondary to absolute glaucoma. Rhegmatogenous retinal detachment (RD) 
occurred in eight (2.2%) eyes; four eyes underwent successful vitreo-retinal procedures and 
these eyes regained the baseline visual acuity. Four eyes were deemed inoperable owing to 
total RD with proliferative vitreoretinopathy. There was no incidence of bleb leakage, bleb-
related infection, or endophthalmitis. 
Table 3 - Complications. 
Complications  No. (%) of eyes  
Operative (postoperative)    
Shallow AC 51 (14.2) 
 Shallow AC (spontaneously formed) 43 (84.3) 
 Shallow AC (required surgical reformation) 8 (15.7) 
Choroidal detachment 1 (0.3) 
Retinal detachment 8 (2.2) 
Enucleation 4 (1.1) 
Anaesthetic  
 Apnea 21 (5.8) 
 Bleeding from trachea 1 (0.3) 
 Cardio-pulmonary arrest 1 (0.3) 
 Delayed recovery 2 (0.6) 
  Responded to treatment 1 (50) 
  Death 1 (50) 
 AC, anterior chamber. 
Anaesthetic complications 
Apnea occurred in 21 (5.8%) patients, who were successfully resuscitated. Anaesthetic 
complication in the form of bleeding from trachea occurred in one patient. This was observed 
during the recovery phase from anaesthesia and was successfully managed. 
The most serious anaesthetic complication was cardio-pulmonary arrest that occurred 5 h 
postoperatively following aspiration during feeding in one child, who could not be 
resuscitated. Two children had delayed recovery (2 and 4 h, respectively) because of 
prematurity (weight at surgery was 2.2 and 2.3 kg, respectively). Both children were shifted 
to the paediatric intensive care unit. The child with 2 h delayed recovery responded well and 
has completed 5 years of follow-up; the other child expired 48 h later. 
Discussion 
The primary objective in the management of PDG is to normalize and permanently control 
the IOP, thereby preventing loss of visual function and preserving the ocular integrity. 
Developmental glaucoma is a worldwide disease and the impact on the visual function is 
extreme. The only effective and definitive form of treatment of most of the PDGs is surgical. 
Traditionally, goniotomy2, 4, 6, 7, 8 or trabeculotomy10, 12, 13, 18, 19, 20, 21, 22, 23 has been the 
procedure of choice amongst the glaucoma specialists. However, goniotomy should never be 
performed without a view of the angle.50 On the other hand, the disadvantage of 
trabeculotomy is that the Schlemm's canal may not be found in 11–15% of the procedures.19, 
28 In view of these limitations, some surgeons have resorted to primary trabeculectomy in the 
management of PDG because primary trabeculectomy is easier than goniotomy or 
trabeculotomy.51, 52, 53, 54, 55 Unfortunately, many of the patients with PDG require multiple 
surgeries to achieve a successful outcome.2, 4, 8, 24, 25, 26 
Over the last decade, 360° trabeculotomy55, 56 and CTT have emerged as alternatives to the 
conventional modes of surgery.27, 28, 29 Of the two, many surgeons have preferred CTT as an 
initial procedure for several ethnic population groups such as Middle East,30, 31 Jerusalem,28 
and India.32, 33, 34, 35, 36 The most compelling argument in favour of primary CTT in our Indian 
patient population was the higher incidence of successful IOP control with a single operative 
procedure, as has already been reported by us.32, 33, 34, 35, 36 The aim of the present study was 
to evaluate the outcome of PDG operated by a single surgeon over a 14.5-year period. 
Kaplan–Meier survival analysis demonstrated the success probabilities of 85.2, 80.4, 77.2, 
72.6, 66.2, and 57.5% at the first, second, third, fourth, fifth, and sixth years, respectively. 
Our success rate with initial surgery is significantly better than most of the reported results of 
initial goniotomy, trabeculotomy ab externo, or primary trabeculectomy. The results of the 
present study are at least as effective as multiple goniotomies and are comparable to the 
results of 360° trabeculotomy.55, 56 Recently, Mendicino et al56 compared the long-term 
surgical results of 360° trabeculotomy and goniotomy and reported significantly better IOP 
control with the former technique, as they believed that it is more standardized than the latter 
technique. We do not have any experience in performing 360° trabeculotomy, but excellent 
IOP control and an efficacy equal to that of multiple standard procedures make it an attractive 
choice among the available angle procedures. Filous and Brunova57 reported the results of 
modified trabeculotomy in the treatment of primary congenital glaucoma, employing 
trabeculotomy probes more closely corresponding to the variable course of Schlemm's canal. 
They reported a success rate of 87% over a mean follow-up of 38.4 22.5 months and 
concluded that probing with the innovative instrument was easier and safer compared to 
standard trabeculotomy probes. We speculate that our success rate of CTT could be further 
enhanced with the use of a modified trabeculotomy probe.57 
Mullaney et al31 and Al-Hazmi et al30 used mitomycin-C (MMC) in primary CTT and 
reported a higher success rate. Our results are comparable to Mullaney et al31 but we do not 
believe in using MMC in primary surgery. However, in cases of failed primary CTT, we 
perform repeat trabeculectomy with MMC as a secondary procedure.58, 59 Whether primary 
CTT is superior to trabeculotomy or trabeculectomy alone is a subject of considerable debate. 
In a small series of seven Arab Bedouin infants, Biender and Rothkoff60 found no difference 
between trabeculotomy and CTT in patients with congenital glaucoma. Dietlein et al61 
investigated the outcome of trabeculotomy, trabeculectomy, and a combined procedure as 
initial surgical treatment in primary congenital glaucoma. Although combined procedure 
seems to have a favourable outcome, the advantages of this procedure over trabeculotomy or 
trabeculectomy were not statistically significant after 2 years. Elder28 compared primary 
trabeculectomy with CTT and found the latter to be superior to the former. In the present 
study, all patients underwent CTT and our results are comparable to those reported by Elder28 
and better than the results of goniotomy, trabeculotomy, or trabeculectomy alone. The 
superior results of the combined procedure may be because of the dual outflow pathway as 
explained by Elder,28 Mandal,33 and Mandal et al.32, 35, 36, 46, 47 Based on our results, we 
believe that CTT may be considered as an initial procedure in PDG. 
In the present series, 243 (67.9%) patients presented with variable degrees of corneal oedema 
and 34 (9.5%) patients presented with corneal scarring that precluded the possibility of 
goniotomy. Postoperatively at the last follow-up visit, 162 (46%) patients had clear corneas. 
Although corneal oedema cleared in about half of the patients, its persistence and the 
development of corneal scarring in the remaining patients was the major reason for visual 
impairment (best-corrected visual acuity <20/60 in the better eye). Nevertheless, IOP was 
under control in these patients. 
The outcome of surgery for PDG is generally reported by IOP control and by life-table 
analysis of success rates.10, 13, 21, 22, 27, 51, 54 The primary purpose of our study was to determine 
the functional outcome of the treated patients. However, at the final postoperative visit, 42 
patients (42.0%) achieved normal visual acuity ( 20/60). Thirty-one patients (31.0%) had 
low vision. Only 27 patients (27.0%) were blind as defined by WHO criteria of vision loss.45 
Literature review revealed that the visual outcomes in PDG have not been consistent.2, 3 and 4, 8, 
23, 24, 25, and 26, 32, 34, 35 and 36, 56, 57, 62, 63 Although our results of visual outcome are not as good as 
those reported by some of these investigators,23, 56, 57 the results are still encouraging because 
most of our patients had earlier onset of the disease and approximately 80% patients 
presented with corneal oedema/scarring. Early clearance of corneal oedema is essential for an 
infant's visual development, and several investigators have suggested that surgery should be 
performed early – within a few days to a few weeks of life.1, 2, 3, 4, 5 In the present study, we 
performed surgery as soon as the patients presented to us. Given the high percentage of 
persistent corneal oedema despite lowering of IOP in our cohort, the benefits of penetrating 
keratoplasty for improved visual outcome were discussed with the parents. 
One of the objectives of the present study was to identify clinically relevant factors that were 
associated with a poor outcome. This objective was achieved by evaluating the role of 
various possible risk factors on the outcome of treatment. The intent was to provide 
predictive information on the risk of failure according to specific patient characteristics at 
baseline. In univariate analysis, several factors were associated with failure. These included 
age of the patient at surgery, preoperative IOP, and a history of prior glaucoma surgery 
(Table 2). Patients who were older than 6 months of age at the time of surgery, with 
preoperative IOP>35 mmHg and who had undergone previous glaucoma surgery had 
approximately twice the risk of failure leading to a poor outcome. The outcome was closely 
linked to the magnitude of the preoperative IOP and to the history of a prior glaucoma 
surgery. Preoperative IOP>35 mmHg was strongly associated with failure, as also the history 
of a prior glaucoma surgery. However, when these two factors coexisted in a small subset of 
patients (n=5), the risk of failure was six times (HR=6.42). Clearly, increased IOP at surgery 
and a repeat surgery are the risk factors associated with a poor outcome. Hence, the present 
study substantiates the fact that the chances of success are highest with the first surgical 
procedure.3, 21 Previous studies have shown another important factor responsible for a poor 
outcome, the earlier onset of disease.1, 2, 3, 4, 5, 9, 10, 11 However, in our study, we cannot 
comment on this factor, as we did not have accurate information regarding the age of onset of 
disease in approximately two-third of our patients (61.4%). This lack of information was 
related to the retrospective nature of our study and poor recall ability of most of the parents 
with regard to the exact time of onset of symptoms. 
In addition to early surgery, appropriate refractive correction coupled with aggressive 
amblyopia therapy is essential for improved visual outcome in patients with PDG.1, 3, 5 
Approximately, three-quarter of our patients (73.8%) were myopic and the mean refraction 
was -6.0 D. Previous investigators have also reported the occurrence of myopia in children 
with PDG.1, 2, 4, 25 Interestingly, we also observed emmetropia in 27 eyes (13.4%) and 
hypermetropia in 26 eyes (12.9%). When we compared the present series to our previously 
reported series on CTT performed within 1 month35 and 6 months of age,36 we observed that 
the incidence of myopia is higher (73.8%) in the current series as opposed to 53.8 and 57.3%, 
respectively. We attribute this higher incidence of myopia to the late presentation and 
advanced nature of PDG in a significantly greater proportion of patients in the present study. 
We speculate that the myopia in the present study was axial in nature. The attendant 
complications of axial myopia ought to be discussed with the parents of children with PDG. 
In the present study, there were no serious intraoperative complications. Of the minor 
postoperative complications, shallow anterior chamber occurred in 51 (14.2%) eyes in the 
first postoperative week; however, surgical reformation was required in only eight (15.7%) 
eyes. In the remainder (43 eyes, 84.3%), the anterior chamber deepened spontaneously. 
One eye (0.3%) developed choroidal detachment that was successfully managed 
conservatively. Four eyes (1.1%) required enucleation because of painful blind eye secondary 
to absolute glaucoma. Rhegmatogenous RD occurred in eight (2.2%) eyes; four eyes 
underwent successful vitreo-retinal procedures and these eyes regained the baseline visual 
acuity. Four eyes were deemed inoperable owing to total RD with proliferative 
vitreoretinopathy. The long-term complications of the present series are comparable to those 
reported by Litinsky et al,64 Shaffer,2 and Shaffer and Hoskins.4 The treating ophthalmologist 
ought to bear in mind the long-term complications as well as the long-term drift in IOP 
control61, 65, 66 when counselling the parents before surgery. 
In the present study, 264 (73.3%) patients underwent simultaneous bilateral surgery to avoid 
another long anaesthesia despite the theoretical risk of endophthalmitis. There was no 
incidence of bleb leakage, bleb-related infection, or endophthalmitis. Based on these results, 
we believe that simultaneous bilateral surgery can be undertaken safely in these tiny 
patients.34 However, strict intraoperative asepsis is mandatory and the second eye should be 
operated as if performing a surgical procedure on a different patient. Nevertheless, the 
decision-making process must involve the treating surgeon, the parents, and the 
anaesthesiologists.34 
The limitations of the present study are its non-randomized, retrospective design and the 
variability in the timing of the surgery that depended on the clearance for anaesthesia and 
variability in the age at presentation. In addition, Snellen acuity data were available only for 
100 (29.6%) patients. 
In conclusion, primary CTT is safe and effective in patients with all types of PDG. Our study 
with PDG achieved prolonged IOP control and experienced good visual outcomes; 42% of 
the patients achieved normal visual acuity. Preoperative IOP>35 mmHg and a history of prior 
failed glaucoma surgery were significant risk factors for poor outcome. The results of this 
study provide useful information relating to the functional outcome and long-term 
complications. Furthermore, because this study reflects the experience of a single surgeon 
over a 14.5-year period, the data may be regarded as the minimum level of achievable 
outcomes for PDG. Such data will help in parental counselling and improve compliance. 
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